
Republicans have called on Twitter CEO Jack Dorsey to testify at Monday’s antitrust hearing, which will feature the CEOs of Amazon, Apple, Facebook and Google.
In a letter to Democratic leadership on Wednesday, Jim Jordan, R-Ohio, wrote, “We believe there is bipartisan interest to hear from Twitter about its power in the marketplace, its role in moderating content on its platform, and the causes for its recent highly publicized security breaches,” a likely reference to last week’s hack that affected the accounts of major figures including former President Barack Obama. The letter was addressed to Judiciary Chairman Jerrold Nadler, D-N.Y.
The call follows ongoing tension between Jordan, the top Republican on the Judiciary Committee, and Democratic leaders over the format of the hearing. Jordan previously asked Nadler to hold the hearing in front of the full committee, rather than before the Antitrust Subcommittee, to allow participation from all members. In Wednesday’s letter, Jordan said that Nadler has so far declined that request.
Jordan described Twitter as “a market leader in social media” and said the hearing “represents a significant and unique opportunity to explore these issues with respect to Twitter as part of the Committee’s investigation.”
But Twitter is much smaller than the four other companies already set to testify, making an antitrust argument against the company more challenging. Though size is not necessarily an indication of anticompetitive behavior in the U.S., Twitter holds far less of the social media market than Facebook. Last quarter, Twitter reported 166 million monetizable daily active users (mDAUs). Though it says that metric is not comparable to those for other platforms, it’s far below the 1.73 billion daily active users (DAUs) Facebook reported last quarter.
Full Content: CNBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Confusion Reigns In AI Policy In US and Europe
May 13, 2025 by
CPI
EU Clears ADNOC’s $16.3 Billion Acquisition of Covestro
May 13, 2025 by
CPI
Spanish Antitrust Chief Says BBVA-Sabadell Merger Won’t Stifle Competition
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas